Contact Us
Please complete the form, and a representative of Intelligent Bio Solutions will contact you shortly to assist with your enquiry.
Our Locations
New York
Intelligent Bio Solutions Inc.
Floor 5, 135 W 41st St,
New York, NY 10036,
United States
+1 646 790 5756
Office Hours
9am – 5pm Monday to Friday
Sydney
Intelligent Bio Solutions Inc.
Level 1, Suite 5,
28-40 Lord Street,
Botany, NSW, 2019
Australia
Office Hours
9am – 5pm Monday to Friday
Cambridge
14-17 Evolution Business Park,
Milton Road, Impington,
Cambridge, CB24 9NG,
United Kingdom
info@intelligentfingerprinting.com
+44 (0)1223 941941
Office Hours
9am – 5pm Monday to Friday
Media Contact
For media enquiries, please contact marketing@ibs.inc.
Investor Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
Find more information at investors.ibs.inc.
Connect With Us
Latest News
Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
NEW YORK, September 01, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its latest Method Comparison Study for its Intelligent Fingerprinting Drug Screening System (the “System”) to detect the opiate codeine. Conducted across three independent U.S….
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
NEW YORK, August 19, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the full year ended June 30, 2026, and provided a business update. “Fiscal 2026 was a year of clear, compounding…
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
NEW YORK, August 17, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its Intelligent Fingerprinting Drug Screening business has been recertified to the ISO 13485:2016 quality management system standard, the internationally recognized benchmark for medical device manufacturers. The…